Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

1

Review clinical trials related to Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.

Participants needed: 48
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Updated: Apr 6, 2026Locations: 26
Eligibility criteria

Age ≥ 18 years old (based on the date of signing the informed consent form); [+8]

Those who currently suffer from epilepsy/myasthenia gravis or have a history of... [+19]